Angela Chen

Angela Chen's work experience includes various roles in the biotechnology and healthcare industry. Angela is currently the Chief Business Officer & Asia GM at WuXi Advanced Therapies. Prior to this, they served as the China GM & Asia Commercial Head at WuXi AppTec Advanced Therapies Unit (ATU) from 2021 to 2023. Angela briefly held the position of CEO at Porton Biologics Ltd. in 2020. From April 2020 to September 2020, they worked as the Global Commercial & Strategy leader for Enterprise at Cytiva. Before that, at GE Healthcare, they held multiple positions including Global Commercial & Strategy leader for Enterprise, Cell & Gene Therapy from April 2019 to April 2020, Business leader, Cell and Gene Therapy, Asia from September 2017 to April 2020, and Business Director, Research & Applied Market, Great China from May 2015 to September 2017. Angela also worked at Sigma Aldrich as the Director of Marketing, Industrial Accounts, and Channel Management from January 2013 to April 2015, and as the Director of Marketing from December 2010 to December 2012. Angela previously held the role of Head, Business Development & Project Management at HD Biosciences from August 2008 to August 2010. Their early career includes a position as a Product Manager at Merck from May 2006 to November 2008 and as a Research Associate at the University of Pittsburgh from May 2002 to June 2006.

Angela Chen's education history includes a Bachelor of Science (BS) degree in Biochemistry from Fudan University, which was completed from 1994 to 1998. Later, they pursued higher education and obtained a PhD degree in Human Genetics from the University of Pittsburgh, where they attended from 1998 to 2002. Finally, Angela completed their Masters in Business Administration (MBA) with a focus on Business Administration and Management from the University of Pittsburgh Katz Graduate School of Business, from 2003 to 2006.